Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition.
Peer, Sebastian
Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition. [electronic resource] - Oncotarget Jun 2017 - 41841-41853 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.18360 doi
Adaptor Proteins, Signal Transducing--deficiency
Animals
Antineoplastic Agents, Immunological--pharmacology
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Cell Proliferation--drug effects
Disease Susceptibility
Female
Immunomodulation--genetics
Interferon-gamma--metabolism
Lymphocyte Activation--genetics
Mice
Mice, Knockout
Neoplasms--drug therapy
Proto-Oncogene Proteins c-cbl--deficiency
T-Lymphocytes--immunology
Tumor Burden--drug effects
Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition. [electronic resource] - Oncotarget Jun 2017 - 41841-41853 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.18360 doi
Adaptor Proteins, Signal Transducing--deficiency
Animals
Antineoplastic Agents, Immunological--pharmacology
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Cell Proliferation--drug effects
Disease Susceptibility
Female
Immunomodulation--genetics
Interferon-gamma--metabolism
Lymphocyte Activation--genetics
Mice
Mice, Knockout
Neoplasms--drug therapy
Proto-Oncogene Proteins c-cbl--deficiency
T-Lymphocytes--immunology
Tumor Burden--drug effects